Evaluation of the agreement between guidelines and initial antihypertensive drug treatment using a national health care reimbursement database

Journal of Evaluation in Clinical Practice

Volumn 18, Issue 3, 2012, Pages 623-629

  Meneton, Pierre ^a,c   Ricordeau, Philippe ^a   Weill, Alain ^a   Tuppin, Philippe ^a   Samson, Solène ^a   Allemand, Hubert ^b   Durieux, Pierre ^c   Ménard, Joël ^c  

^a INSERM   (France)

^b Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

French population; guidelines; hypertension; initial drug treatment; national health care reimbursement database

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; DATA BASE; DIABETIC PATIENT; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REIMBURSEMENT;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DATABASES AS TOPIC; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 84860883401     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2011.01640.x     Document Type: Article

References (40)

1. Berlowitz, D. R., Ash, A. S., Hickey, E. C., Friedman, R. H., Glickman, M., Kader, B., &, Moskowitz, M. A., (1998) Inadequate management of blood pressure in a hypertensive population. The New England Journal of Medicine, 339, 1957-1963. (Pubitemid 29024127)
2. Burnier, M., (2002) Blood pressure control and the implementation of guidelines in clinical practice: can we fill the gap? Journal of Hypertension, 20, 1251-1253. (Pubitemid 34925660)
3. Cranney, M., Warren, E., Barton, S., Gardner, K., &, Walley, T., (2001) Why do GPs not implement evidence-based guidelines? A descriptive study. Family Practice, 18, 359-363. (Pubitemid 32771637)
4. de la Sierra, A., Zamorano, J. L., &, Ruilope, L. M., (2009) Application of hypertension guidelines in clinical practice: implementation of the 2007 ESH/ESC European practice Guidelines in Spain. Journal of Hypertension. Supplement, 27, S27-S32.
5. Frijling, B. D., Spies, T. H., Lobo, C. M., Hulscher, M. E., van Drenth, B. B., Braspenning, J. C., Prins, A., van der Wouden, J. C., &, Grol, R. P., (2001) Blood pressure control in treated hypertensive patients: clinical performance of general practitioners. The British Journal of General Practice, 51, 9-14. (Pubitemid 32015750)
6. Oliveria, S. A., Lapuerta, P., McCarthy, B. D., L'Italien, G. J., Berlowitz, D. R., &, Asch, S. M., (2002) Physician-related barriers to the effective management of uncontrolled hypertension. Archives of Internal Medicine, 162, 413-420. (Pubitemid 34150642)
7. Wyszewianski, L., Kowalski, C., Lowery, J., &, Green, L. A., (2007) Does implementation of evidence-based guidelines follow the available evidence? Implementation of hypertension guidelines at Veterans Affairs medical centers. Quality Management in Health Care, 16, 174-181.
8. Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P. A., &, Rubin, H. R., (1999) Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA, 282, 1458-1465. (Pubitemid 29493800)
9. Alanen, S., Ijas, J., Kaila, M., Makela, M., &, Valimaki, M., (2008) Hypertension guideline implementation: experiences of Finnish primary care nurses. Journal of Evaluation in Clinical Practice, 14, 830-835.
10. Aucott, J. N., Pelecanos, E., Dombrowski, R., Fuehrer, S. M., Laich, J., &, Aron, D. C., (1996) Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system. Journal of General Internal Medicine, 11, 139-146.
11. Cuspidi, C., Michev, I., Lonati, L., et al,. (2002) Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy. Journal of Human Hypertension, 16, 699-703. (Pubitemid 35396503)
12. Hagemeister, J., Schneider, C. A., Barabas, S., Schadt, R., Wassmer, G., Mager, G., Pfaff, H., &, Hopp, H. W., (2001) Hypertension guidelines and their limitations-the impact of physicians' compliance as evaluated by guideline awareness. Journal of Hypertension, 19, 2079-2086. (Pubitemid 33035814)
13. Heneghan, C., Perera, R., Mant, D., &, Glasziou, P., (2007) Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence. The British Journal of General Practice, 57, 948-952.
14. Hetlevik, I., Holmen, J., Kruger, O., &, Holen, A., (1997) Fifteen years with clinical guidelines in the treatment of hypertension-still discrepancies between intentions and practice. Scandinavian Journal of Primary Health Care, 15, 134-140. (Pubitemid 27397844)
15. Petek-Ster, M., Kersnik, J., &, Svab, I., (2007) Compliance with hypertension guidelines in general practice in Slovenia. Srpski Arhiv za Celokupno Lekarstvo, 135, 191-196.
16. Schellevis, F. G., van Eijk, J. T., Lisdonk, E. H., Velden, J., &, van Weel, C., (1994) Implementing guidelines in general practice. Evaluation of process and outcome of care in chronic diseases. International Journal for Quality in Health Care, 6, 257-266.
17. Troein, M., Gardell, B., Selander, S., &, Rastam, L., (1997) Guidelines and reported practice for the treatment of hypertension and hypercholesterolaemia. European Journal of Internal Medicine, 242, 173-178. (Pubitemid 27351616)
18. Wagner, N., Pittrow, D., Kirch, W., Kupper, B., Krause, P., Hofler, M., Bramlage, P., &, Wittchen, H. U., (2004) [The use of guidelines in the primary care management of hypertension and diabetes]. Sozial- und Praventivmedizin, 49, 261-268. (Pubitemid 39117555)
19. Wang, L., (2004) Physician-related barriers to hypertension management. Medical Principles and Practice, 13, 282-285. (Pubitemid 39179143)
20. Avanzini, F., Tognoni, G., Alli, C., Colombo, F., &, Herxheimer, A., (1996) How informed general practitioners manage mild hypertension: a survey of readers of drug bulletins in 7 countries. International Society of Drug Bulletins (ISDB). European Journal of Clinical Pharmacology, 49, 445-450.
21. Martin-Latry, K., &, Begaud, B., (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiology and Drug Safety, 19, 256-265.
22. National Agency for Accreditation and Evaluation in Healthcare (2000) Prise en charge des patients adultes atteints d'hypertension artérielle essentielle. Paris: National Agency for Accreditation and Evaluation in Healthcare.
23. National Authority for Health (2005) Prise en charge des patients adultes atteints d'hypertension artérielle essentielle. Paris: National Authority for Health.
24. Tuppin, P., de Roquefeuil, L., Weill, A., Ricordeau, P., &, Merliere, Y., (2010) French national health insurance information system and the permanent beneficiaries sample. Revue d'Epidemiologie et de Sante Publique, 58, 286-290.
25. Eshaghian, S., Horwich, T. B., &, Fonarow, G. C., (2006) Relation of loop diuretic dose to mortality in advanced heart failure. The American Journal of Cardiology, 97, 1759-1764. (Pubitemid 43817867)
26. J-MELODIC (2007) Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC). Circulation Journal, 71, 1137-1140.
27. Ouzounian, M., Hassan, A., Cox, J. L., Johnstone, D. E., &, Howlett, J., (2007) The effect of spironolactone use on heart failure mortality: a population-based study. Journal of Cardiac Failure, 13, 165-169. (Pubitemid 46590039)
28. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., &, Wittes, J., (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. The New England Journal of Medicine, 341, 709-717. (Pubitemid 29407370)
29. Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., &, Redelmeier, D. A., (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. The New England Journal of Medicine, 351, 543-551. (Pubitemid 39025171)
30. Bero, L. A., Grilli, R., Grimshaw, J. M., Harvey, E., Oxman, A. D., &, Thomson, M. A., (1998) Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ, 317, 465-468. (Pubitemid 28368041)
31. Chalmers, J., (1999) Implementation of guidelines for management of hypertension. Clinical and Experimental Hypertension, 21, 647-657. (Pubitemid 29325465)
32. Drouin, D., Campbell, N. R., &, Kaczorowski, J., (2006) Implementation of recommendations on hypertension: the Canadian Hypertension Education Program. The Canadian Journal of Cardiology, 22, 595-598. (Pubitemid 44044215)
33. Goldstein, M. K., Lavori, P., Coleman, R., Advani, A., &, Hoffman, B. B., (2005) Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations. The American Journal of Managed Care, 11, 677-685. (Pubitemid 41608209)
34. Karagiannis, A., Hatzitolios, A. I., Athyros, V. G., et al,. (2009) Implementation of guidelines for the management of arterial hypertension. The impulsion study. Open Cardiovascular Medicine Journal, 3, 26-34.
35. Martin, I., (1999) Implementation of WHO/ISH Guidelines: role and activities of WHO. Clinical and Experimental Hypertension, 21, 659-669. (Pubitemid 29325466)
36. National Agency for Accreditation and Evaluation in Healthcare (2000) Efficacité des méthodes de mise en æuvre des recommandations médicales. Paris: National Agency for Accreditation and Evaluation in Healthcare.
37. Gagliardi, A. R., Brouwers, M. C., Palda, V. A., Lemieux-Charles, L., &, Grimshaw, J. M., (2009) An exploration of how guideline developer capacity and guideline implementability influence implementation and adoption: study protocol. Implementation Science, 4, 36.
38. McAlister, F. A., Campbell, N. R., Zarnke, K., Levine, M., &, Graham, I. D., (2001) The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ, 164, 517-522. (Pubitemid 32187911)
39. Onion, C. W., &, Walley, T., (1995) Clinical guidelines: development, implementation, and effectiveness. Postgraduate Medical Journal, 71, 3-9.
40. Latry, P., Molimard, M., Begaud, B., &, Martin-Latry, K., (2010) How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. European Journal of Clinical Pharmacology, 66, 743-748.